Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 2
2001 11
2002 9
2003 14
2004 28
2005 35
2006 52
2007 86
2008 81
2009 84
2010 87
2011 85
2012 79
2013 67
2014 63
2015 75
2016 64
2017 46
2018 45
2019 24
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

874 results
Results by year
Filters applied: . Clear all
Page 1
Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M. Merroun I, et al. Metabolism. 2013 Nov;62(11):1641-50. doi: 10.1016/j.metabol.2013.06.011. Epub 2013 Aug 6. Metabolism. 2013. PMID: 23932644
Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
Skosnik PD, Hajós M, Cortes-Briones JA, Edwards CR, Pittman BP, Hoffmann WE, Sewell AR, D'Souza DC, Ranganathan M. Skosnik PD, et al. Neuropharmacology. 2018 Jun;135:412-423. doi: 10.1016/j.neuropharm.2018.03.036. Epub 2018 Mar 28. Neuropharmacology. 2018. PMID: 29604295 Free PMC article. Clinical Trial.
874 results
Jump to page
Feedback